Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma [Phase 1]
Phase 1 trial evaluating CLN-619, an anti-MICA/MICB antibody, in relapsed/refractory multiple myeloma. The study is active but not recruitin…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients [Phase 3]
This entry announces a Phase 3 clinical trial of CM336 for relapsed or refractory multiple myeloma that is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients [Phase 1]
Phase 1 trial evaluating Itacitinib with high-dose posttransplantation cyclophosphamide in older patients. The study is currently ACTIVE_NOT…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating teclistamab in combination therapy in elderly patients with multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1, Phase 2]
Biotroy Therapeutics is conducting a Phase 1/2 study of BT02 for relapsed or refractory hematologic malignancies, with recruitment not yet s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: HEME Home Transfusion Program [NA]
Clinical trial update indicates that the HEME Home Transfusion Program is currently recruiting for hematologic conditions including leukemia…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma [Phase 1]
This clinical trial update reports a Phase 1 study of ATLCAR.CD138 cells for relapsed/refractory multiple myeloma, with the study listed as …
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma [Phase 1]
A Phase 1 trial of a BCMA-CD19 CAR-T cell therapy for relapsed/refractory multiple myeloma and plasmacytoid lymphoma is currently recruiting…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Risk-adapted Therapeutic Strategy in +1q NDMM
Clinical trial update announcing a risk-adapted therapeutic strategy for newly diagnosed multiple myeloma with +1q abnormalities. The study …
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration [Phase 3]
SWOG's Phase 3 trial S1803 is evaluating lenalidomide with or without daratumumab/rHuPH20 as post-autologous stem cell transplant maintenanc…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Integrated Actionable Aging Assessment for Cancer Patients Pilot [NA]
This entry summarizes a pilot trial from University of Colorado, Denver to develop an integrated aging assessment for cancer patients; the s…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
This clinical trial update describes a study assessing vaccine responses in patients who previously received CAR-T therapy for multiple myel…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide [Phase 2]
This Phase 2 trial evaluates health-related quality of life in people with multiple myeloma treated with daratumumab or lenalidomide. The st…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients
An observational study is evaluating the combination of selinexor with bortezomib and dexamethasone for multiple myeloma and is currently re…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy [Phase 2]
A Phase 2 clinical trial update assessing early and late consolidation/maintenance therapy for multiple myeloma, with the study currently ac…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies [EARLY_Phase 1]
This open-label, single-arm Phase 1 study is currently recruiting to evaluate the safety and preliminary efficacy of OriV508 injections in a…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
A Phase 3 trial evaluates bortezomib- or carfilzomib-based regimens with lenalidomide and dexamethasone in newly diagnosed multiple myeloma.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CC-92480 (BMS-986348) in combination with other treatments for relapsed or refractory multiple myeloma…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM) [Phase 4]
This document provides a Phase 4 clinical trial update on the Pneumococcal Conjugate Vaccine 13 (PCV13) for patients with multiple myeloma, …
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
This clinical trial update describes an ongoing study assessing a health technology intervention aimed at improving patient activation in pe…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Early Assessment of Cardiac Function After Treatment With CAR-T Cells
A clinical trial update reporting early cardiac function assessment in patients treated with CAR-T cell therapy for hematologic malignancies…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma [Phase 2]
Phase 2 clinical trial updating on the combination of belantamab mafodotin, pomalidomide, and dexamethasone for high-risk plasma cell myelom…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 sub-study evaluating belantamab mafodotin in combination with nirogacestat, lenalidomide, an…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 trial evaluating a dendritic cell/multiple myeloma fusion vaccine in combination with elranatamab for relapsed or refractory multipl…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells
This clinical trial update outlines an approach to prevent graft-versus-host disease after allogeneic hematopoietic cell transplantation by …